<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02925078</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00095933</org_study_id>
    <nct_id>NCT02925078</nct_id>
  </id_info>
  <brief_title>Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars</brief_title>
  <official_title>The Influence of Mucosa Tissue Thickness on Marginal Bone Loss of Implants With Smooth Collars: A Prospective Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to compare the amount of implant marginal bone loss&#xD;
      radiographically and probing depth in between thin and thick mucosa group that will receive a&#xD;
      machined collar implant.&#xD;
&#xD;
      Null hypothesis is mucosa thickness does not affect implant marginal bone loss on implant&#xD;
      with smooth collar.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty eight adult patients who fulfill the inclusion criteria will be divided into 2 groups&#xD;
      based upon the mucosa thickness (&lt;2 mm and ≥2 mm). A signed written informed consent will be&#xD;
      obtained from all subjects. Subjects will not be screened or treated until an informed&#xD;
      consent has been obtained. Patient information will be protected according to the privacy&#xD;
      regulations of the federal Health Insurance Portability and Accountability Act of 1996&#xD;
      (HIPAA).&#xD;
&#xD;
      The enrolled patients will receive implants with 1 mm polished collar. Implants will be&#xD;
      restored at 4 (±1) months after placement. Outcome analyses will be performed until 1 (±1&#xD;
      month) year after loading and clinical and radiographic parameters will be evaluated to&#xD;
      compare clinical outcomes between groups. The primary outcome is implant marginal bone loss&#xD;
      and probing depth from clinical and radiographic measurements.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 21, 2016</start_date>
  <completion_date type="Actual">December 16, 2019</completion_date>
  <primary_completion_date type="Actual">December 16, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radiographic Peri-implant Bone Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.</measure>
    <time_frame>12 months</time_frame>
    <description>Radiographic change in remaining bone level (measured in millimeters) between the surgery visit (baseline) and the 12 month follow up visit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peri-implant Probing Depth Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.</measure>
    <time_frame>12 months</time_frame>
    <description>Change in probing depths (measured in millimeters) around the dental implant between the crown delivery visit and the 12 month follow-up visit.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Gingival Tissue</condition>
  <arm_group>
    <arm_group_label>&lt;2 mm mucosa thickness</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have &lt;2 mm mucosa thickness.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>≥2 mm mucosa thickness</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have ≥2 mm mucosa thickness.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT)</intervention_name>
    <description>Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
    <arm_group_label>&lt;2 mm mucosa thickness</arm_group_label>
    <arm_group_label>≥2 mm mucosa thickness</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or Female&#xD;
&#xD;
          -  Aged ≥18&#xD;
&#xD;
          -  In need of one dental implant in the Maxillary or Mandibular area, can be an anterior,&#xD;
             premolar, or 1st molar tooth&#xD;
&#xD;
          -  Natural adjacent teeth&#xD;
&#xD;
          -  Bone height of ≥10mm&#xD;
&#xD;
          -  Bone width of ≥5mm&#xD;
&#xD;
          -  Good oral hygiene&#xD;
&#xD;
          -  Stable periodontium&#xD;
&#xD;
          -  Willingness to fulfill all study requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Need bone augmentation&#xD;
&#xD;
          -  Need one dental implant that is a 2nd or 3rd molar tooth&#xD;
&#xD;
          -  Current smoker or quit smoking less than one year&#xD;
&#xD;
          -  Pregnant or plan to get pregnant&#xD;
&#xD;
          -  Uncontrolled diabetes (HbA1C &gt; 7)&#xD;
&#xD;
          -  Medical conditions that may influence the outcome of the study (neurologic or&#xD;
             psychiatric disorders, systemic infections )&#xD;
&#xD;
          -  Current use of oral bisphosphonates&#xD;
&#xD;
          -  History of IV bisphosphonates&#xD;
&#xD;
          -  History of radiation therapy in the head and neck area within 4 years&#xD;
&#xD;
          -  Poor oral hygiene (plaque score more than 40% based on O'Leary plaque score)&#xD;
&#xD;
          -  Once a group has been filled, subjects who meet the criteria of that group will be&#xD;
             excluded&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hom-Lay Wang, DDS MSD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Periodontics and Oral Medicine University of Michigan School of Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan School of Dentistry</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Berglundh T, Lindhe J. Dimension of the periimplant mucosa. Biological width revisited. J Clin Periodontol. 1996 Oct;23(10):971-3.</citation>
    <PMID>8915028</PMID>
  </reference>
  <reference>
    <citation>Linkevicius T, Apse P, Grybauskas S, Puisys A. The influence of soft tissue thickness on crestal bone changes around implants: a 1-year prospective controlled clinical trial. Int J Oral Maxillofac Implants. 2009 Jul-Aug;24(4):712-9.</citation>
    <PMID>19885413</PMID>
  </reference>
  <reference>
    <citation>Balshe AA, Assad DA, Eckert SE, Koka S, Weaver AL. A retrospective study of the survival of smooth- and rough-surface dental implants. Int J Oral Maxillofac Implants. 2009 Nov-Dec;24(6):1113-8.</citation>
    <PMID>20162117</PMID>
  </reference>
  <reference>
    <citation>Ochsenbein C, Ross S. A reevaluation of osseous surgery. Dent Clin North Am. 1969 Jan;13(1):87-102.</citation>
    <PMID>5249439</PMID>
  </reference>
  <reference>
    <citation>Anderegg CR, Metzler DG, Nicoll BK. Gingiva thickness in guided tissue regeneration and associated recession at facial furcation defects. J Periodontol. 1995 May;66(5):397-402.</citation>
    <PMID>7623260</PMID>
  </reference>
  <reference>
    <citation>Claffey N, Shanley D. Relationship of gingival thickness and bleeding to loss of probing attachment in shallow sites following nonsurgical periodontal therapy. J Clin Periodontol. 1986 Aug;13(7):654-7.</citation>
    <PMID>3531244</PMID>
  </reference>
  <reference>
    <citation>Abrahamsson I, Berglundh T, Wennström J, Lindhe J. The peri-implant hard and soft tissues at different implant systems. A comparative study in the dog. Clin Oral Implants Res. 1996 Sep;7(3):212-9.</citation>
    <PMID>9151585</PMID>
  </reference>
  <reference>
    <citation>Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants. 1986 Summer;1(1):11-25. Review.</citation>
    <PMID>3527955</PMID>
  </reference>
  <reference>
    <citation>Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol. 2013 Apr;84(4):436-43. doi: 10.1902/jop.2013.134001. Review.</citation>
    <PMID>23537178</PMID>
  </reference>
  <reference>
    <citation>Aparna IN, Dhanasekar B, Lingeshwar D, Gupta L. Implant crest module: a review of biomechanical considerations. Indian J Dent Res. 2012 Mar-Apr;23(2):257-63. doi: 10.4103/0970-9290.100437. Review.</citation>
    <PMID>22945720</PMID>
  </reference>
  <reference>
    <citation>Wennerberg A, Albrektsson T, Andersson B. Design and surface characteristics of 13 commercially available oral implant systems. Int J Oral Maxillofac Implants. 1993;8(6):622-33.</citation>
    <PMID>8181824</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 3, 2016</study_first_submitted>
  <study_first_submitted_qc>October 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2016</study_first_posted>
  <results_first_submitted>October 1, 2020</results_first_submitted>
  <results_first_submitted_qc>October 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 26, 2020</results_first_posted>
  <last_update_submitted>October 1, 2020</last_update_submitted>
  <last_update_submitted_qc>October 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Hom-Lay Wang, DDS, MSD, Ph D</investigator_full_name>
    <investigator_title>Professor of Dentistry and Director of Graduate Periodontics</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 19, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/78/NCT02925078/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>&lt;2 mm Mucosa Thickness</title>
          <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have &lt;2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
        </group>
        <group group_id="P2">
          <title>≥2 mm Mucosa Thickness</title>
          <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have ≥2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>&lt;2 mm Mucosa Thickness</title>
          <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have &lt;2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
        </group>
        <group group_id="B2">
          <title>≥2 mm Mucosa Thickness</title>
          <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have ≥2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.54" lower_limit="36" upper_limit="69"/>
                    <measurement group_id="B2" value="56.54" lower_limit="40" upper_limit="75"/>
                    <measurement group_id="B3" value="56.54" lower_limit="36" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                    <count group_id="B2" value="13"/>
                    <count group_id="B3" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Radiographic Peri-implant Bone Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.</title>
        <description>Radiographic change in remaining bone level (measured in millimeters) between the surgery visit (baseline) and the 12 month follow up visit.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>&lt;2 mm Mucosa Thickness</title>
            <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have &lt;2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
          </group>
          <group group_id="O2">
            <title>≥2 mm Mucosa Thickness</title>
            <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have ≥2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Peri-implant Bone Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.</title>
          <description>Radiographic change in remaining bone level (measured in millimeters) between the surgery visit (baseline) and the 12 month follow up visit.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" spread="0.66"/>
                    <measurement group_id="O2" value="0.61" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Peri-implant Probing Depth Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.</title>
        <description>Change in probing depths (measured in millimeters) around the dental implant between the crown delivery visit and the 12 month follow-up visit.</description>
        <time_frame>12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>&lt;2 mm Mucosa Thickness</title>
            <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have &lt;2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
          </group>
          <group group_id="O2">
            <title>≥2 mm Mucosa Thickness</title>
            <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have ≥2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
          </group>
        </group_list>
        <measure>
          <title>Peri-implant Probing Depth Change (Measured in Millimeters) Between Baseline and 12 Months Follow-up.</title>
          <description>Change in probing depths (measured in millimeters) around the dental implant between the crown delivery visit and the 12 month follow-up visit.</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.65" spread="0.62"/>
                    <measurement group_id="O2" value="1.35" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected during each subject's entire participation in the study (approximately 1.5 years)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>&lt;2 mm Mucosa Thickness</title>
          <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have &lt;2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
        </group>
        <group group_id="E2">
          <title>≥2 mm Mucosa Thickness</title>
          <description>A Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT) will be placed in subjects that have ≥2 mm mucosa thickness.&#xD;
Biohorizons Tapered Internal Implant, Laser-Lok, Resorbable Blast Textured (RBT): Placement of implant in a subject with &lt;2 mm mucosa thickness or a subject with ≥2 mm mucosa thickness.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Hip replacement</sub_title>
                <description>The subject enrolled in the study and at the time did not inform the study team of any need of a hip replacement. 11 months later, the subject told the study team that he had to have his left hip replaced.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Coordinator</name_or_title>
      <organization>University of Michigan</organization>
      <phone>7347633346</phone>
      <email>aliceou@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

